{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:40:54Z","timestamp":1792269654809,"version":"4.4.0"},"reference-count":13,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,8,21]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>A man in his early 60s with previously well-controlled hypertension developed sudden deterioration in blood pressure control 2\u2009weeks after starting isoniazid\u2013rifampin therapy for latent tuberculosis infection. His blood pressure had previously been stable on an angiotensin receptor blocker and a calcium channel blocker. He presented with a headache and newly uncontrolled hypertension. Rather than representing progression of essential hypertension, the deterioration was temporally associated with rifampicin-induced cytochrome P450 enzyme induction. Rifampin is a potent inducer of CYP3A4 and can reduce plasma concentrations of calcium channel blockers such as amlodipine by up to approximately 80%, substantially diminishing their antihypertensive effect. Blood pressure improved after escalation of antihypertensive therapy while antituberculosis treatment continued without interruption. This case highlights the importance of structured medication review when evaluating sudden loss of blood pressure control in primary care.<\/jats:p>","DOI":"10.1136\/bcr-2026-273417","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:35:18Z","timestamp":1788593718000},"page":"e273417","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Loss of blood pressure control after rifampin initiation: a clinically significant antihypertensive drug\u2013drug interaction"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-9074","authenticated-orcid":false,"given":"Joomong","family":"Park","sequence":"first","affiliation":[{"name":"Department of Public Health, Sacheon City Public Health Center, Sacheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"2026090500501424000_19.9.e273417.1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"2026090500501424000_19.9.e273417.2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0090-9556(25)08415-6","article-title":"The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism","volume":"24","author":"Holtbecker","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"2026090500501424000_19.9.e273417.3","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31814a586a"},{"key":"2026090500501424000_19.9.e273417.4","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000084"},{"key":"2026090500501424000_19.9.e273417.5","first-page":"557","article-title":"Hypertension Canada\u2019s 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults","volume":"33","author":"Leung","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026090500501424000_19.9.e273417.6","doi-asserted-by":"publisher","DOI":"10.1021\/tx700079z"},{"key":"2026090500501424000_19.9.e273417.7","doi-asserted-by":"crossref","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2026090500501424000_19.9.e273417.8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJM198504043121414","article-title":"Reduction of bioavailability of verapamil by rifampin","volume":"312","author":"Rahn","year":"1985","journal-title":"N Engl J Med"},{"key":"2026090500501424000_19.9.e273417.9","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2026090500501424000_19.9.e273417.10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/fcp.12292","article-title":"Rifampicin reverses nicardipine effect inducing uncontrolled essential hypertension","volume":"31","author":"Cordeanu","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"key":"2026090500501424000_19.9.e273417.11","first-page":"591","article-title":"Resistant hypertension during antituberculosis treatment: how is rifampicin implicated?","volume":"75","author":"Lee","year":"2020","journal-title":"Med J Malaysia"},{"key":"2026090500501424000_19.9.e273417.12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bcp.13848","article-title":"Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine","volume":"85","author":"Sunwoo","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"2026090500501424000_19.9.e273417.13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-254699","article-title":"Rifampicin-induced hypertensive urgency: eyes see what the mind knows","volume":"16","author":"Gaba","year":"2023","journal-title":"BMJ Case Rep"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-273417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:50:23Z","timestamp":1788594623000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-273417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":13,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,4]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bcr-2026-273417"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-273417","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}